» Authors » Jiri Molacek

Jiri Molacek

Explore the profile of Jiri Molacek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 146
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Havlickova K, Kostakova E, Lisnenko M, Hauzerova S, Stuchlik M, Vrchovecka S, et al.
Polymers (Basel) . 2024 Apr; 16(8). PMID: 38674949
The use of electrospun polymeric biodegradable materials for medical applications is becoming increasingly widespread. One of the most important parameters regarding the functionality of nanofiber scaffolds during implantation and the...
2.
Prochazkova K, Vojtisek R, Vodicka J, Horova J, Hosek P, Skala M, et al.
Rep Pract Oncol Radiother . 2024 Mar; 28(6):746-755. PMID: 38515821
Background/objective: Hormone receptor (HR) status is one of the key factors in determining the treatment of breast cancer. Previous studies suggested that HR status may change in metastatic tissue. However,...
3.
Molacek J, Treska V, Skalicky T, Vodicka J, Ferda J, Ferdova E, et al.
Front Oncol . 2023 Feb; 13:1057683. PMID: 36793610
Background: Castleman´s disease is an extremely rare heterogenous lymphoproliferative pathology with a mostly benign behavior. It is a localized or generalized lymph node enlargement of an unknown aetiology. Unicentric form...
4.
Adorni M, Palumbo M, Marchi C, Zimetti F, Ossoli A, Turri M, et al.
Front Immunol . 2022 Sep; 13:935241. PMID: 36172376
Background: The etiopathogenesis of abdominal aortic aneurysm (AAA) is still unclarified, but vascular inflammation and matrix metalloproteases activation have a recognized role in AAA development and progression. Circulating lipoproteins are...
5.
Troup O, Skalicky A, Vistejnova L, Klein P, Maleckova A, Florova B, et al.
In Vivo . 2022 Apr; 36(3):1083-1094. PMID: 35478151
Background/aim: Patients with unresectable liver colorectal cancer metastases are treated with neoadjuvant chemotherapy often accompanied by biological therapy aimed at reducing the mass of metastases and thus increasing the chances...
6.
Molacek J, Treska V, Houdek K, Opatrny V, Certik B, Baxa J
Antibiotics (Basel) . 2022 Mar; 11(3). PMID: 35326849
Introduction: Vascular graft infection is a life threatening situation with significant morbidity and mortality. Bacterial graft infection can lead to false aneurysms, bleeding and sepsis. There are a lot of...
7.
Opatrny V, Treska V, Zeithaml J, Hes O, Matejka R, Molacek J
Transplant Proc . 2021 Jul; 53(6):2082-2090. PMID: 34274120
Background: Donation after circulatory death donors are becoming a common source of organs for transplant. Despite good long-term outcomes of grafts from donation after circulatory death, this group is affected...
8.
Treska V, Molacek J, Certik B, Houdek K, Hosek P, Soukupova V, et al.
In Vivo . 2021 Jan; 35(1):517-523. PMID: 33402504
Background/aim: As the population ages, there are increasing findings of coincidental diseases such as abdominal aortic aneurysm (AAA) and intra-abdominal, retroperitoneal malignancy. The aim of this study was to propose...
9.
Opatrny V, Treska V, Waloschek T, Molacek J
SAGE Open Med Case Rep . 2020 Oct; 8:2050313X20959874. PMID: 33088569
Spleen tumors are an uncommon disease. Littoral cell angioma belongs to the group of vascular tumors. It is believed that this tumor originates from the tissue of the red pulp...
10.
Cerna V, Ostasov P, Pitule P, Molacek J, Treska V, Pesta M
Cardiol Res Pract . 2019 Dec; 2019:8645840. PMID: 31885906
Background: Abdominal aortic aneurysms (AAA) are relatively frequent in elderly population, and their ruptures are related with high mortality rate. There are no actually used laboratory markers predicting the AAA...